(Q47823834)

5 February 2018

review article

1 reference

title

Serotonin, anxiety, and stress hormones. Focus on 5-HT receptor subtypes, species and gender differences. (English)

1 reference

5 February 2018

0 references

1

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

5 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

5 February 2018

volume

851

1 reference

5 February 2018

page(s)

357-363

1 reference

5 February 2018

Serotonergic mechanisms in anxiety

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

The 5-HT1A receptor is not involved in emotional stress-induced rises in stress hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

m-Chlorophenylpiperazine as a probe of serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Serotonin function in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09009.X

10.1111/J.1749-6632.1998.TB09009.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9668626

1 reference

5 February 2018